Associate Director – Health Economics & Outcomes Research, Oncology

🕒 il y a 25 jours

🇺🇸 États-Unis – Télétravail

💵 $191 800 - $239 800 / an

⏰ Temps Plein

🟠 Senior

👔 Directeur

🦅 Parrain de Visa H1B

Cette entreprise a parrainé des visas H1B par le passé.

👻 Score fantôme 2%

Ce que ça veut dire : la probabilité que cette offre reste ouverte sans recrutement actif.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Configurer une alerte email pour les nouveaux emplois

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV

Natera

Site WebLinkedInTous les Emplois

1001 - 5000 employés

Fondée en 2004

🏥 Santé

🧬 Biotechnologie

⚕️ Assurance santé

Healthcare • Biotechnology • Healthcare Insurance

Natera est un leader mondial de la technologie de tests d'ADN libre circulant, spécialisé dans les tests génétiques non invasifs et les diagnostics. Les solutions innovantes de l'entreprise se concentrent sur des domaines tels que le dépistage prénatal, la détection du cancer et la surveillance des greffes d'organes. En utilisant une bioinformatique avancée et une analyse de l'ADN, Natera fournit aux professionnels de la santé et aux patients des informations cruciales pour prendre des décisions médicales plus éclairées.

Description

• Lead development, validation, and application of health economic models, including budget impact, cost-effectiveness, cost-utility, cost-consequence, ROI, decision-tree, Markov/state-transition, and partitioned-survival models • Develop scenario and sensitivity analyses quantifying the clinical and economic value of precision diagnostics • Partner with Clinical Development, Medical Affairs, Biostatistics, and cross-functional teams to integrate HEOR objectives into prospective clinical studies • Incorporate healthcare resource utilization, economic endpoints, patient-reported outcomes, quality-of-life measures, cost-data collection, and real-world evidence strategies into evidence plans • Analyze clinical-trial, observational, and real-world datasets • Evaluate resource utilization, cost of care, treatment pathways, diagnostic utilization, clinical utility, comparative effectiveness, patient outcomes, survival, budget impact, and quality-adjusted life years • Lead HEOR publication strategy and develop manuscripts, abstracts, posters, oral presentations, white papers, and technical reports • Coordinate publication plans with investigators, key opinion leaders, academic collaborators, and external research partners • Translate HEOR evidence into payer value propositions, budget impact summaries, value dossiers, reimbursement materials, health economic briefs, value calculators, and account-specific economic tools • Develop and adapt health economic evidence and payer models for U.S. and international markets • Support reimbursement submissions and evidence strategies aligned with HTA and payer requirements • Serve as a strategic HEOR partner across Medical Affairs, Clinical Development, Biostatistics, Market Access, Commercial, Marketing, Regulatory, and Business Development • Collaborate with external consultants, academic investigators, KOLs, and research partners

🎯 Exigences

• Advanced degree (PhD, PharmD, MD, DrPH, or Master's degree) in Health Economics, Outcomes Research, Epidemiology, Public Health, Biostatistics, Pharmacy, Health Services Research, or a related discipline • 5–10+ years of HEOR experience within biotechnology, pharmaceuticals, diagnostics, medical devices, consulting, academia, or a related healthcare environment • Demonstrated experience developing and applying health economic models and conducting outcomes research using clinical-trial and/or real-world datasets • Experience supporting payer evidence generation, reimbursement strategy, value dossiers, market access initiatives, and scientific publications • Experience with precision medicine, molecular diagnostics, companion diagnostics, ctDNA, molecular residual disease (MRD), donor-derived cell-free DNA (dd-cfDNA), next-generation sequencing, biomarker-guided treatment strategies, or oncology diagnostics is highly desirable • Familiarity with Microsoft Excel, TreeAge Pro, R, SAS, STATA, Python, SQL, Tableau/Power BI, and statistical analysis software is preferred

🏖️ Avantages

• Annual performance incentive bonus • Long-term equity awards • Comprehensive health benefits (medical, dental, vision) • 401(k) with company match • Generous paid time off and company holidays • Additional wellness and work-life benefits • Life and disability plans for eligible employees and dependents • Free testing for employees and immediate families • Fertility care benefits • Pregnancy and baby bonding leave • Commuter benefits • Employee referral program